Quality of life in patients with primary hyperparathyroidism in the Chuvash Republic

Author:

Aizetullova G. A.1,Osipov V. F.1,Kichigin V. A.2

Affiliation:

1. Republican Clinical Hospital for War Veterans of the Ministry of Health of Chuvashia; I.N. Ulyanov Chuvash State University

2. GAU DPO Institute of Advanced Medical Training

Abstract

Anthropometric data, indicators of laboratory and instrumental examinations were prospectively studied in 80 patients with primary hyperparathyroidism who were treated at the Republican Clinical Hospital for War Veterans of the Ministry of Health of Chuvashia. The quality of life of all patients with primary hyperparathyroidism was assessed before and after surgical treatment using two questionnaires: the SF-36 questionnaire and the standardized quality of life questionnaire for patients with PGPT — PHQol, an adapted Russian version of the quality of life questionnaire for primary hyperparathyroidism. As a result of the study, primary hyperparathyroidism was found to be a disease with a low level of detectability due to low awareness of practitioners, therefore, it often takes up to 10 years from the onset of the disease to diagnosis. It is necessary to introduce screening programs to determine the level of calcium in the blood. The disease primary hyperparathyroidism is of medical and economic importance, which pushes us to pay closer attention to this disease, to create a register of patients with primary hyperparathyroidism. Assessment of the quality of life before and after surgical treatment makes it possible to assess the subjective state of the patient, and also contributes to a patient-oriented approach in the management of patients with PGPT. The standardized questionnaire for assessing the quality of life in hyperparathyroidismPHQoL, its adapted and validated Russian version is a reliable method for studying the quality of life before and after surgical treatment of patients with PGPT, as well as for evaluating the effectiveness of surgical treatment.

Publisher

Endocrinology Research Centre

Subject

General Medicine

Reference18 articles.

1. Rossiiskaia assotsiatsiia endokrinologov. Klinicheskie rekomendatsii. Pervichnyi giperparatireoz. Moscow: Ministerstvo zdravookhraneniya RF; 2016. (In Russ.).

2. Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959. doi: https://doi.org/10.1001/jamasurg.2016.2310

3. Mokrysheva NG. Pervichnyi giperparatireoz. Epidemiologiia, klinika, sovremennye printsipy diagnostiki i lecheniia. [dissertation] Moscow; 2011. (In Russ.).

4. Farkhutdinova LM. Pervichnyi giperparatireoz: problemy i puti resheniia. Meditsinskii vestnik Bashkortostana. 2010;5(1):65-70. (In Russ.).

5. Ferraz-de-Souza B. The evolution of primary hyperparathyroidism. Arch Endocrinol Metab. 2015;59(5):381-382. doi: https://doi.org/10.1590/2359-3997000000124

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3